These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 20622918)

  • 21. Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events.
    O'Shea O; Stovold E; Cates CJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD007694. PubMed ID: 33852162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-world effects of once vs greater daily inhaled corticosteroid dosing on medication adherence.
    Wells KE; Peterson EL; Ahmedani BK; Williams LK
    Ann Allergy Asthma Immunol; 2013 Sep; 111(3):216-20. PubMed ID: 23987199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ciclesonide versus other inhaled corticosteroids for chronic asthma in children.
    Kramer S; Rottier BL; Scholten RJ; Boluyt N
    Cochrane Database Syst Rev; 2013 Feb; (2):CD010352. PubMed ID: 23450613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serious Asthma Outcomes and Asthma Exacerbations with Maintenance on Inhaled Corticosteroid (Mometasone Furoate)/Long-Acting Beta Agonist (Formoterol) Combination Compared to Step Down to Mometasone Monotherapy.
    Weinstein CLJ; Ryan N; Zhang X; Shekar T; Gates D; Lane SJ; Agache I; Nathan RA;
    J Allergy Clin Immunol Pract; 2020 May; 8(5):1634-1644.e1. PubMed ID: 31981733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
    Chan J; Hui RL; Spence MM
    J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vilanterol and fluticasone furoate for asthma.
    Dwan K; Milan SJ; Bax L; Walters N; Powell C
    Cochrane Database Syst Rev; 2016 Sep; 9(9):CD010758. PubMed ID: 27582089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mometasone furoate in the management of asthma: a review.
    Tan RA; Corren J
    Ther Clin Risk Manag; 2008 Dec; 4(6):1201-8. PubMed ID: 19337427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Inhaled Corticosteroid Detection for Monitoring Adherence in Severe Asthma.
    Alahmadi FH; Keevil B; Elsey L; George K; Niven R; Fowler SJ
    J Allergy Clin Immunol Pract; 2021 Dec; 9(12):4279-4287.e6. PubMed ID: 34153519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management.
    Singh D; Garcia G; Maneechotesuwan K; Daley-Yates P; Irusen E; Aggarwal B; Boucot I; Berend N
    Adv Ther; 2022 May; 39(5):1895-1914. PubMed ID: 35284999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mometasone furoate dry-powder inhaler for the control of persistent asthma.
    D'Urzo A
    Expert Opin Pharmacother; 2007 Nov; 8(16):2871-84. PubMed ID: 17956206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence and asthma control with mometasone furoate versus fluticasone propionate in adolescents and young adults with mild asthma.
    Friedman HS; Navaratnam P; McLaughlin J
    J Asthma; 2010 Nov; 47(9):994-1000. PubMed ID: 20831468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of Adherence and Asthma Medication Ratio for a Once-Daily and Twice-Daily Inhaled Corticosteroid/Long-Acting β-Agonist for Asthma.
    Stanford RH; Averell C; Parker ED; Blauer-Peterson C; Reinsch TK; Buikema AR
    J Allergy Clin Immunol Pract; 2019; 7(5):1488-1496.e7. PubMed ID: 30639604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term safety of mometasone furoate administered via a dry powder inhaler in children: Results of an open-label study comparing mometasone furoate with beclomethasone dipropionate in children with persistent asthma.
    Noonan M; Leflein J; Corren J; Staudinger H
    BMC Pediatr; 2009 Jul; 9():43. PubMed ID: 19594937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.
    Stempel DA; Riedel AA; Carranza Rosenzweig JR
    Curr Med Res Opin; 2006 Mar; 22(3):463-70. PubMed ID: 16574030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved asthma control after changing from low-to-medium doses of other inhaled corticosteroids to low-dose fluticasone propionate.
    Stoloff SW; Srebro SH; Edwards LD; Johnson MC; Rickard KA
    MedGenMed; 2001 Jun; 3(3):2. PubMed ID: 11549975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized, double-blind study to compare the efficacy and safety of two doses of mometasone furoate delivered via Breezhaler® or Twisthaler® in patients with asthma.
    Buhl R; Tanase AM; Hosoe M; Cao W; Demin I; Bartels C; Jauernig J; Ziegler D; Patalano F; Hederer B; Kanniess F; Tillmann HC
    Pulm Pharmacol Ther; 2020 Jun; 62():101919. PubMed ID: 32387408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence and Adherence to ICS/LABA Drugs in UK Patients with Asthma: A Retrospective New-User Cohort Study.
    Parimi M; Svedsater H; Ann Q; Gokhale M; Gray CM; Hinds D; Nixon M; Boxall N
    Adv Ther; 2020 Jun; 37(6):2916-2931. PubMed ID: 32361850
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting.
    Chastek B; Korrer S; Nagar SP; Albers F; Yancey S; Ortega H; Forshag M; Dalal AA
    J Manag Care Spec Pharm; 2016 Jul; 22(7):848-61. PubMed ID: 27348285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.
    Crossingham I; Turner S; Ramakrishnan S; Fries A; Gowell M; Yasmin F; Richardson R; Webb P; O'Boyle E; Hinks TS
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013518. PubMed ID: 33945639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhaled fluticasone propionate: a review of its therapeutic efficacy at dosages < or = 500 microg/day in adults and adolescents with mild to moderate asthma.
    Jarvis B; Faulds D
    Drugs; 1999 May; 57(5):769-803. PubMed ID: 10353302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.